Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1981
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
C10AB04
|
| gptkbp:brand |
gptkb:gemfibrozil
|
| gptkbp:CASNumber |
25812-30-0
|
| gptkbp:chemicalFormula |
C15H22O3
|
| gptkbp:contraindication |
severe liver disease
gallbladder disease |
| gptkbp:drugClass |
fibrate
|
| gptkbp:eliminationHalfLife |
1.5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lopid
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:mechanismOfAction |
PPAR-alpha agonist
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
muscle pain
gastrointestinal upset |
| gptkbp:usedFor |
hyperlipidemia
hypertriglyceridemia |
| gptkbp:bfsParent |
gptkb:gemfibrozil
|
| gptkbp:bfsLayer |
6
|